Literature DB >> 7688366

Human immunodeficiency virus reverse transcriptase. Expression in Escherichia coli, purification, and characterization of a functionally and structurally asymmetric dimeric polymerase.

R L Thimmig1, C S McHenry.   

Abstract

Human immunodeficiency virus (HIV) reverse transcriptase isolated from viral particles contains two subunits, p51 and p66. We have produced both subunits in separate Escherichia coli strains using expression vectors. Stop codons were placed immediately after the codon for the carboxyl-terminal residue of the mature processed p51 and p66 subunits found in viral particles. Insertion of a methionine in front of the HIV protease cleavage site in the recombinant protein enabled synthesis of both subunits with the natural amino-terminal proline, since E. coli methionine aminopeptidase cleaves a Met-Pro amino-terminal linkage. That this occurred to an extent greater than 95% was confirmed by sequencing the purified subunits. Examination of the activities of the individual p51 and p66 subunits on a variety of templates and under solution conditions optimized for each subunit revealed a significant catalytic activity for the natural p51 subunit. This result contrasts to results reported earlier for many recombinant forms without the natural amino and/or carboxyl termini. As expected from earlier work, the optimal homopolymeric template for the p66 subunit was poly(rA). For the p51 subunit, poly(dC) was found to be the optimal template; its activity is 2- to 4-fold greater than p66 on poly(dC). The p51 subunit is 13- to 50-fold less active on poly(rC). These findings are discussed in the context of our earlier hypothesis (McHenry, C. S. (1989) in Molecular Biology of Chromosome Function (Adolph, K., ed) Chap. 5, Springer-Verlag, New York) that the HIV reverse transcriptase might be functionally asymmetric with distinct plus- and minus-strand polymerases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688366

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Solution characterization of [methyl-(13)C]methionine HIV-1 reverse transcriptase by NMR spectroscopy.

Authors:  Xunhai Zheng; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Antiviral Res       Date:  2009-08-07       Impact factor: 5.970

2.  The large subunit of HIV-1 reverse transcriptase interacts with beta-actin.

Authors:  M Hottiger; K Gramatikoff; O Georgiev; C Chaponnier; W Schaffner; U Hübscher
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

3.  Cloning and expression of a human T-lymphotropic virus type 1 protein with reverse transcriptase activity.

Authors:  S M Owen; R B Lal; R A Ikeda
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.

Authors:  Luis R Miranda; Matthias Götte; Fei Liang; Daniel R Kuritzkes
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits.

Authors:  M Amacker; M Hottiger; U Hübscher
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins.

Authors:  B Berkhout; F J van Hemert
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

7.  Human immunodeficiency virus-1 reverse transcriptase heterodimer stability.

Authors:  J Lebowitz; S Kar; E Braswell; S McPherson; D L Richard
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.